When to choose cardiac resynchronization therapy in chronic heart failure: type and duration of the conduction delay
Cristina Balla1, Riccardo Cappato2
1Cardiovascular Center, University of Ferrara, Ferrara, Italy.
Insights
Cardiac resynchronization therapy (CRT) improves heart failure (HF) outcomes. Patient selection for CRT is evolving, with left bundle branch block morphology now recognized as a key predictor of therapy response.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is a standard treatment for heart failure (HF) patients with impaired left ventricular (LV) function and wide QRS complex.
- Initial CRT patient selection relied on QRS duration, but recent evidence highlights the importance of QRS morphology, particularly left bundle branch block (LBBB), for predicting treatment response.
- Conventional right ventricular apical pacing can negatively impact cardiac structure and LV function, potentially causing or worsening HF.
Purpose of the Study:
- To review current knowledge on selecting candidates for CRT.
- To focus on how conduction delays causing LV electrical and mechanical dyssynchrony influence patient selection.
- To emphasize the role of QRS morphology in optimizing CRT outcomes.
Main Methods:
- Review of current scientific literature and clinical trial data on CRT patient selection.
- Analysis of the impact of QRS duration versus QRS morphology (specifically LBBB) on CRT efficacy.
- Examination of guidelines recommending CRT upgrades or de novo implantation based on pacing burden and LV function.
Main Results:
- Left bundle branch block morphology is a significant predictor of positive response to CRT.
- Guidelines now recommend CRT for patients with high ventricular pacing percentages and reduced ejection fraction (EF), considering upgrades or new implants.
- Conduction delays leading to LV dyssynchrony are critical factors in CRT candidacy.
Conclusions:
- Patient selection for CRT is increasingly refined beyond simple QRS duration to include specific QRS morphologies like LBBB.
- Optimizing CRT candidate selection based on electrical dyssynchrony can improve therapeutic outcomes in heart failure patients.
- CRT offers a valuable therapeutic option for selected HF patients, with evolving criteria enhancing its effectiveness.
Abstract:
Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and wide QRS complex. The initial randomized clinical trials, which led to the widespread use of CRT, selected patients on the basis of QRS duration, not focusing on QRS morphology. However, recent evidences emphasized the role of left bundle branch block morphology in patients that underwent CRT in order to predict better response to therapy. Moreover, conventional right ventricular apical pacing might have long-term detrimental effects on cardiac structure and LV function, possibly leading to the development of HF. Therefore, current guidelines recommend upgrade from conventional pacemaker or implantable cardioverter-defibrillator to CRT or de novo CRT in patients with high (or expected high) percentage of ventricular pacing and reduced EF. We reviewed current knowledge on candidates' selection for CRT based on conduction delays that lead to electrical and mechanical dyssynchrony of the left ventricle.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction


